Payden & Rygel’s Cintas CTAS Stock Holding History

Payden & Rygel’s Portfolio CTAS Stock Details CTAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-108,400	Closed	-$13M	–	138
2023 Q3	$13M	Buy	+108,400	New	+$13.5M	0.89%	48

Other funds holding CTAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Payden & Rygel's CTAS Position: Q4 2023 in Review

Payden & Rygel sold out of Cintas (CTAS) in Q4 2023, closing a stake of 108,400 shares — an estimated $13M sold.

Payden & Rygel first reported a position in CTAS in Q3 2023 and held it in 1 quarter. The position peaked at $13M in Q3 2023. 1,165 funds tracked by Wall St. Rank hold CTAS as of Q4 2023.

Payden & Rygel reported no remaining Cintas position as of Q4 2023 after selling out during the quarter.
Payden & Rygel sold 108,400 Cintas shares in Q4 2023, an estimated $13M.
Payden & Rygel first reported a position in Cintas in Q3 2023 and held it in 1 quarter.
Payden & Rygel's Cintas position peaked at $13M in Q3 2023.
1,165 funds tracked by Wall St. Rank held Cintas as of Q4 2023.

Based on Payden & Rygel's 13F filing for Q4 2023, filed 13 Feb 2024.